Mefoxin  - Drug Details
📊 Estimates Mefoxin  Dialyzability By Different_Modalities

Mefoxin 

Complete Drug Information

Drug Name
Mefoxin 
Trade Names
Mefoxin, Renoxitin
Pregnancy Category
AU: B1
Routes of Administration
Intravenous
Metabolism
minimal
Elimination
41-59 min
Excretion
85% urine
Formula
C16H17N3O7S2
Molar Mass
427.45
Melting Point
149 to 150 °C
Volume of Distribution
C16H17N3O7S2

🤰 Pregnancy Category Information

Category: AU: B1

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have not shown evidence of an increased occurrence of fetal damage.